Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature

IF 2.9 3区 医学 Q2 DERMATOLOGY
Manuel Winkler, Jana Dorothea Albrecht, Christian Sauer, Theresa Kordaß, Emmanuella Guenova, Elisabeth Livingstone, Marion Wobser, Christina Mitteldorf, Cyrill Géraud, Jan Peter Nicolay
{"title":"Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature","authors":"Manuel Winkler,&nbsp;Jana Dorothea Albrecht,&nbsp;Christian Sauer,&nbsp;Theresa Kordaß,&nbsp;Emmanuella Guenova,&nbsp;Elisabeth Livingstone,&nbsp;Marion Wobser,&nbsp;Christina Mitteldorf,&nbsp;Cyrill Géraud,&nbsp;Jan Peter Nicolay","doi":"10.1111/1346-8138.17339","DOIUrl":null,"url":null,"abstract":"<p>Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a subtype of cutaneous B-cell lymphoma with unfavorable prognosis usually requiring aggressive polychemotherapy for disease control. Only single cases of spontaneous regression of PCDLBCL, LT are reported in the literature, peaking 3 months post-biopsy following a clinical history of no longer than 1 year. Here, we report the first case of a spontaneously relapsing and remitting PCDLBCL, LT with complete regression after a clinical history of more than 9 years and thus an atypically indolent clinical course. The female patient presented with recurrent erythematous, non-ulcerated, non-raised plaques of the right lower leg for 6 years. Pathological workup and exclusion of a systemic disease confirmed the diagnosis of PCDLBCL, LT. Due to the history of repeated spontaneous remission, no therapy was initiated. Nine years after first occurrence the patient presented with complete clinical remission lasting for 64 months. We retrospectively identified four additional PCDLBCL, LT patients with spontaneous remission lasting up to 53 months. Our data provide evidence for a distinct PCDLBCL, LT patient subgroup that clinicians should be aware of and warrants a watch-and-wait treatment regime.</p>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"51 9","pages":"1233-1239"},"PeriodicalIF":2.9000,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.17339","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17339","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT) is a subtype of cutaneous B-cell lymphoma with unfavorable prognosis usually requiring aggressive polychemotherapy for disease control. Only single cases of spontaneous regression of PCDLBCL, LT are reported in the literature, peaking 3 months post-biopsy following a clinical history of no longer than 1 year. Here, we report the first case of a spontaneously relapsing and remitting PCDLBCL, LT with complete regression after a clinical history of more than 9 years and thus an atypically indolent clinical course. The female patient presented with recurrent erythematous, non-ulcerated, non-raised plaques of the right lower leg for 6 years. Pathological workup and exclusion of a systemic disease confirmed the diagnosis of PCDLBCL, LT. Due to the history of repeated spontaneous remission, no therapy was initiated. Nine years after first occurrence the patient presented with complete clinical remission lasting for 64 months. We retrospectively identified four additional PCDLBCL, LT patients with spontaneous remission lasting up to 53 months. Our data provide evidence for a distinct PCDLBCL, LT patient subgroup that clinicians should be aware of and warrants a watch-and-wait treatment regime.

Abstract Image

原发性皮肤弥漫大 B 细胞淋巴瘤(腿型)的自然消退:系列病例和文献综述。
原发性皮肤弥漫大B细胞淋巴瘤腿型(PCDLBCL,LT)是皮肤B细胞淋巴瘤的一种亚型,预后不良,通常需要积极的多化疗来控制病情。文献中仅有单例 PCDLBCL LT 自发消退的报道,临床病史不超过 1 年,在活检后 3 个月达到高峰。在此,我们报告了首例自发复发和缓解的 PCDLBCL、LT 病例,患者在超过 9 年的临床病史后完全消退,因此临床病程不典型。这名女性患者的右小腿反复出现红斑、非溃疡、非隆起性斑块已有 6 年之久。经病理检查并排除全身性疾病后,确诊为PCDLBCL,LT。由于有反复自发缓解的病史,因此没有开始治疗。首次发病九年后,患者的临床症状完全缓解,持续了 64 个月。我们又回顾性地发现了另外四名自发缓解长达 53 个月的 PCDLBCL、LT 患者。我们的数据为一个独特的 PCDLBCL、LT 患者亚群提供了证据,临床医生应对此有所了解,并应采取观察和等待的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Dermatology
Journal of Dermatology 医学-皮肤病学
CiteScore
4.60
自引率
9.70%
发文量
368
审稿时长
4-8 weeks
期刊介绍: The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences. Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信